Search This Blog

Monday, March 1, 2021

BeiGene cut to Underperform by CLSA

 From Outperform; target to $321 from $330

https://finviz.com/quote.ashx?t=BGNE

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.